{"symbol":"PFE","fiscalQuarter":"Q3-2017","reportDate":"2017-10-31","reportTime":"BMO","status":"reported","company":{"name":"Pfizer Inc.","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/PFE/earnings/Q3-2017","postBrief":{"headline":"Pfizer Beats on EPS, Stock Down 0.26%","keyNumbers":[{"metric":"EPS","actual":"$0.67","expected":"N/A","surprise":"+1.14%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted ongoing developments in their pipeline.","They emphasized the importance of innovation in driving future growth."],"summary":"Overall, management expressed a positive outlook on their product pipeline. However, they did not provide specific guidance for the upcoming quarters."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Pfizer's earnings report showed a slight beat on EPS, which may indicate better-than-expected profitability. However, the stock reacted negatively, declining by 0.26%. This could suggest investor concerns about future revenue growth or lack of guidance.","metaDescription":"Pfizer Inc (PFE) Q3 2017 earnings: EPS beat by 1.14%. Stock down 0.26%. Full breakdown."}}